AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimilife M 3mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Lakshya Pharma Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Glimilife M 3mg/500mg Tablet SR

Diabetic patients using Glimilife M 3mg/500mg SR tablets, an anti-diabetic medication combining two active ingredients, should adhere to their prescribed dosage. This dual-action formulation effectively manages blood glucose levels in adult type 2 diabetes. Consistent daily intake, ideally with meals, maximizes efficacy. Dosage adjustments are determined by your physician based on blood sugar monitoring. Discontinuing this medication without medical guidance risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. Glimilife M 3mg/500mg SR is a component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as recommended by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are crucial for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before starting treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, alongside blood tests to assess blood cell counts and liver function, are recommended under your doctor’s supervision.

Uses of Glimilife M 3mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimilife M 3mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Glimilife M 3mg/500mg Sustained-Release tablets should be taken with a meal.

Common Side effects of Glimilife M 3mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimilife M 3mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimilife M 3mg/500mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.

How Glimilife M 3mg/500mg Tablet SR works:

Glimilife M 3mg/500mg Extended-Release tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glimilife M 3mg/500mg SR tablet use is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimilife M 3mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimilife M 3mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimilife M 3mg/500mg Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. For patients exhibiting severe kidney disease, Glimilife M 3mg/500mg Tablet SR is contraindicated. Close monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimilife M 3mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Individuals with severe liver disease should avoid this medication. A low initial dose is usually prescribed for those with mild to moderate liver disease. Physician consultation is advised.

What if you forget to take Glimilife M 3mg/500mg Tablet SR :

Should you forget to take a Glimilife M 3mg/500mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Glimilife M 3mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimilife M 3mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimilife M 3mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Glimilife M and seek immediate medical attention.
Glimilife M 3mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimilife M 3mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Glimilife M 3mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and gait problems), urinary issues, cognitive changes, and balance difficulties. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Glimilife M 3mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimilife M 3mg/500mg SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimilife M 3mg/500mg Tab...
86
MRP 105
18% off